Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Wacker BK et al. Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2. 2009 Stroke pmid:19644058
Scherer EQ et al. Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. 2010 Stroke pmid:20930159
Yagi K et al. Therapeutically Targeting Tumor Necrosis Factor-α/Sphingosine-1-Phosphate Signaling Corrects Myogenic Reactivity in Subarachnoid Hemorrhage. 2015 Stroke pmid:26138121
Chen JJ et al. Non-genomic rapid responses via progesterone in human peripheral T cells are not indirectly mimicked by sphingosine 1-phosphate. 2014 Steroids pmid:24269742
Klyachkin YM et al. Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute Infarction. 2015 Stem Cells Transl Med pmid:26371341
Kang H et al. The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension. 2015 Stem Cells Dev. pmid:25761906
Avery K et al. Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. 2008 Stem Cells Dev. pmid:18393631
Linz-McGillem LA et al. Cytoskeletal rearrangement and caspase activation in sphingosine 1-phosphate-induced lung capillary tube formation. 2004 Stem Cells Dev. pmid:15588507
Marfia G et al. The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling. 2016 Stem Cells Dev. pmid:27217090
Inniss K and Moore H Mediation of apoptosis and proliferation of human embryonic stem cells by sphingosine-1-phosphate. 2006 Stem Cells Dev. pmid:17253942
Karapetyan AV et al. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. 2013 Stem Cells Dev. pmid:23282236
Rodgers A et al. Sphingosine 1-phosphate regulation of extracellular signal-regulated kinase-1/2 in embryonic stem cells. 2009 Stem Cells Dev. pmid:19228106
Wong RC et al. Anti-apoptotic effect of sphingosine-1-phosphate and platelet-derived growth factor in human embryonic stem cells. 2007 Stem Cells Dev. pmid:18047416
Ogle ME et al. Sphingosine-1-Phosphate Receptor-3 Supports Hematopoietic Stem and Progenitor Cell Residence Within the Bone Marrow Niche. 2017 Stem Cells pmid:28026131
Lee H et al. Bone marrow-derived mesenchymal stem cells prevent the loss of Niemann-Pick type C mouse Purkinje neurons by correcting sphingolipid metabolism and increasing sphingosine-1-phosphate. 2010 Stem Cells pmid:20201063
Pébay A et al. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. 2005 Nov-Dec Stem Cells pmid:16081668
Donati C et al. Sphingosine 1-phosphate mediates proliferation and survival of mesoangioblasts. 2007 Stem Cells pmid:17464089
Kimura A et al. Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. 2007 Stem Cells pmid:16990586
Meriane M et al. Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cells. 2006 Stem Cells pmid:16931773
Adamiak M et al. The Involvment of Hematopoietic-Specific PLC -β2 in Homing and Engraftment of Hematopoietic Stem/Progenitor Cells. 2016 Stem Cell Rev pmid:27704316
Wysoczynski M et al. Identification of heme oxygenase 1 (HO-1) as a novel negative regulator of mobilization of hematopoietic stem/progenitor cells. 2015 Stem Cell Rev pmid:25086571
Ratajczak MZ and Suszynska M Emerging Strategies to Enhance Homing and Engraftment of Hematopoietic Stem Cells. 2016 Stem Cell Rev pmid:26400757
Ryu JM et al. Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways. 2014 Stem Cell Res pmid:24145189
Park SW et al. Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. 2010 Shock pmid:19752779
Winkler MS et al. Sphingosine-1-Phosphate: A Potential Biomarker and Therapeutic Target for Endothelial Dysfunction and Sepsis? 2017 Shock pmid:27922551
Nicol GD Nerve growth factor, sphingomyelins, and sensitization in sensory neurons. 2008 Sheng Li Xue Bao pmid:18958367
Zhang GQ et al. Sphingosine-1-phosphate receptors respond differently to early myocardial ischemia and ischemia-reperfusion in vivo. 2014 Sheng Li Xue Bao pmid:24777407
Yu Y and Qin SC [An active lipid signaling molecule: sphingosine-1-phosphate and its biological characteristics]. 2011 Sheng Li Ke Xue Jin Zhan pmid:21770269
Wang J et al. [Sphingolipid and apoptosis]. 2003 Sheng Li Ke Xue Jin Zhan pmid:14628466
Duan HF et al. [Progress in the study of physiological function of sphingosine 1-phosphate]. 2003 Sheng Li Ke Xue Jin Zhan pmid:12778803
Baumruker T and Prieschl EE Sphingolipids and the regulation of the immune response. 2002 Semin. Immunol. pmid:11884231
Anliker B and Chun J Cell surface receptors in lysophospholipid signaling. 2004 Semin. Cell Dev. Biol. pmid:15271291
Pyne S et al. Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. 2004 Semin. Cell Dev. Biol. pmid:15271294
Young KW and Nahorski SR Intracellular sphingosine 1-phosphate production: a novel pathway for Ca2+ release. 2001 Semin. Cell Dev. Biol. pmid:11162743
Gudipaty SA and Rosenblatt J Epithelial cell extrusion: Pathways and pathologies. 2017 Semin. Cell Dev. Biol. pmid:27212253
Hla T Physiological and pathological actions of sphingosine 1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271296
Payne SG et al. Modulation of adaptive immune responses by sphingosine-1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271297
Oskouian B and Saba JD Death and taxis: what non-mammalian models tell us about sphingosine-1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271298
Willis MA and Cohen JA Fingolimod therapy for multiple sclerosis. 2013 Semin Neurol pmid:23709211
Obinata H and Hla T Sphingosine 1-phosphate in coagulation and inflammation. 2012 Semin Immunopathol pmid:21805322
Kihara A [Multifunctional sphingolipid, sphingosine (long-chain base) 1-phosphate: physiological role, metabolism, and intracellular dynamics]. 2006 Seikagaku pmid:16986722
Okamoto Y et al. [Cardiovascular function of sphingosine 1-phosphate signaling]. 2011 Seikagaku pmid:21800684
Kawahara A [Genetic dissection of cardiac morphogenesis in zebrafish]. 2011 Seikagaku pmid:21706872
Okajima F et al. [Role of S1P in the lipoprotein-induced actions and their signaling mechanism]. 2009 Seikagaku pmid:19522297
Fukushima N [A family of lysophospholipid receptors]. 2000 Seikagaku pmid:11076202
Okada T and Nakamura S [Role of S1P acting both inside and outside the cells]. 2012 Seikagaku pmid:22550899
Fukuhara S and Mochizuki N [Lymphocytes mobilization into blood regulated by Spns2, a sphingosine 1-phosphate transporter, expressed on endothelial cells]. 2013 Seikagaku pmid:23717873
Kihara A [Complete metabolic pathway of sphingosine 1-phosphate and its importance as a metabolic intermediate]. 2013 Seikagaku pmid:23980469
Young N and Van Brocklyn JR Signal transduction of sphingosine-1-phosphate G protein-coupled receptors. 2006 ScientificWorldJournal pmid:16906327
Tilly JL Emerging technologies to control oocyte apoptosis are finally treading on fertile ground. 2001 ScientificWorldJournal pmid:12805661
Chun J Immunology. The sources of a lipid conundrum. 2007 Science pmid:17431159
Hait NC et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. 2009 Science pmid:19729656
Kawahara A et al. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. 2009 Science pmid:19074308
Hla T Immunology. Dietary factors and immunological consequences. 2005 Science pmid:16150998
Schwab SR et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. 2005 Science pmid:16151014
Hla T et al. Lysophospholipids--receptor revelations. 2001 Science pmid:11729304
Huang Y et al. S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. 2018 Science pmid:29302015
Mandala S et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. 2002 Science pmid:11923495
Hobson JP et al. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. 2001 Science pmid:11230698
Pappu R et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. 2007 Science pmid:17363629
Lee MJ et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. 1998 Science pmid:9488656
Hla T and Im DS Cell biology. The ABCs of lipophile transport. 2009 Science pmid:19213902
Thathiah A et al. The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. 2009 Science pmid:19213921
Arnon TI et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. 2011 Science pmid:21960637
Sullards MC and Merrill AH Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. 2001 Sci. STKE pmid:11752637
Riccio A New endogenous regulators of class I histone deacetylases. 2010 Sci Signal pmid:20051592
Eichner A and Sixt M Setting the clock for recirculating lymphocytes. 2011 Sci Signal pmid:22067458
Jung M et al. Lipocalin 2 from macrophages stimulated by tumor cell-derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis. 2016 Sci Signal pmid:27353364
Rodvold JJ and Zanetti M Tumor microenvironment on the move and the Aselli connection. 2016 Sci Signal pmid:27353363
Swendeman SL et al. An engineered S1P chaperone attenuates hypertension and ischemic injury. 2017 Sci Signal pmid:28811382
Cai Y et al. FOXF1 maintains endothelial barrier function and prevents edema after lung injury. 2016 Sci Signal pmid:27095594
Xiang SY et al. PLCε, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart. 2013 Sci Signal pmid:24345679
Parrill AL et al. Structure of the first sphingosine 1-phosphate receptor. 2012 Sci Signal pmid:22623751
Galvani S et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. 2015 Sci Signal pmid:26268607
Andrieu G et al. Sphingosine 1-phosphate signaling through its receptor S1P promotes chromosome segregation and mitotic progression. 2017 Sci Signal pmid:28351953
Panneer Selvam S et al. Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation. 2015 Sci Signal pmid:26082434
Trinh HK et al. Exploration of the Sphingolipid Metabolite, Sphingosine-1-phosphate and Sphingosine, as Novel Biomarkers for Aspirin-exacerbated Respiratory Disease. 2016 Sci Rep pmid:27830727
Zhang H et al. Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to Assisted Release Mechanism via the ApoM Calyx-Opening. 2016 Sci Rep pmid:27476912
Jin J et al. Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate. 2016 Sci Rep pmid:26948042
Ko P et al. Extracellular Matrix Rigidity-dependent Sphingosine-1-phosphate Secretion Regulates Metastatic Cancer Cell Invasion and Adhesion. 2016 Sci Rep pmid:26877098
Wiltshire R et al. Regulation of human cerebro-microvascular endothelial baso-lateral adhesion and barrier function by S1P through dual involvement of S1P1 and S1P2 receptors. 2016 Sci Rep pmid:26813587
Sheridan GK and Dev KK Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations. 2014 Sci Rep pmid:24851861
Moruno Manchon JF et al. Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy. 2015 Sci Rep pmid:26477494
Patmanathan SN et al. Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2. 2016 Sci Rep pmid:27160553
Yang L et al. Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice. 2015 Sci Rep pmid:26324256
Checa A et al. Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment. 2015 Sci Rep pmid:26174087
Xie Z et al. Targeting sphingosine-1-phosphate signaling for cancer therapy. 2017 Sci China Life Sci pmid:28623546
Ma Y et al. Sphingosine-1-phosphate (S1P) mediates darkness-induced stomatal closure through raising cytosol pH and hydrogen peroxide (Hâ‚‚Oâ‚‚) levels in guard cells in Vicia faba. 2012 Sci China Life Sci pmid:23090064
Martino A et al. Sphingosine 1-phosphate interferes on the differentiation of human monocytes into competent dendritic cells. 2007 Scand. J. Immunol. pmid:17212771
Yatomi Y [Elucidation of the functional roles of lysophospholipid mediators and its application in laboratory medicine]. 2006 Rinsho Byori pmid:16913663
Ohkawa R et al. [Sphingolipids, possible biomarkers for atherosclerotic disorders]. 2013 Rinsho Byori pmid:24369591
Kimura T et al. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis]. 2007 Rinsho Byori pmid:17511266
Fujii S [Atherosclerosis, Chronic Inflammation, and Thrombosis: In Search of the Missing Link in Laboratory Medicine]. 2015 Rinsho Byori pmid:26524900
Chapurlat RD and Confavreux CB Novel biological markers of bone: from bone metabolism to bone physiology. 2016 Rheumatology (Oxford) pmid:26790456
Kikuta J et al. S1P-targeted therapy for elderly rheumatoid arthritis patients with osteoporosis. 2011 Rheumatol. Int. pmid:21113810
Rivera R and Chun J Biological effects of lysophospholipids. 2008 Rev. Physiol. Biochem. Pharmacol. pmid:18481029
Carr JM et al. Sphingosine kinase 1 in viral infections. 2013 Rev. Med. Virol. pmid:22639116
García-Merino JA and Sánchez AJ [Basic mechanisms of action of fingolimod in relation to multiple sclerosis]. 2012 Rev Neurol pmid:22718407
Varo-Sánchez GM et al. [Pharmacological targets in multiple sclerosis]. 2011 Rev Neurol pmid:21678322
Barnawi J et al. Reduced DNA methylation of sphingosine-1 phosphate receptor 5 in alveolar macrophages in COPD: A potential link to failed efferocytosis. 2017 Respirology pmid:27868302